Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Circulation
|
November 28, 2001
Sympathetic activation by sildenafil
S D Katz, D V Parums
Circulation
|
July 1, 1993
Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors
S D Katz, M Schwarz, J Yuen, et al.
Circulation
|
April 27, 1999
Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure
S D Katz, T Khan, G A Zeballos, et al.
Circulation
|
January 1, 1992
Control of arteriolar resistance in heart failure. Partial attenuation of specific phosphodiesterase inhibitor-mediated vasodilation by digitalis glycosides
G Jondeau, M Klapholz, S D Katz, et al.
Circulation
|
April 1, 1994
Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure
M Schwarz, S D Katz, L Demopoulos, et al.
Circulation
|
November 1, 1992
Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure
G Jondeau, S D Katz, L Zohman, et al.
Circulation
|
July 1, 1994
Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation
S D Katz, R Rao, J W Berman, et al.
Circulation
|
December 15, 1996
Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial
L S Marcus, D Hart, M Packer, et al.
Circulation
|
April 1, 1997
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure
L Demopoulos, M Yeh, M Gentilucci, et al.
Circulation
|
March 2, 1999
Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure
G Hamroff, S D Katz, D Mancini, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Circulation
|
November 28, 2001
Sympathetic activation by sildenafil
S D Katz, D V Parums
Circulation
|
July 1, 1993
Impaired acetylcholine-mediated vasodilation in patients with congestive heart failure. Role of endothelium-derived vasodilating and vasoconstricting factors
S D Katz, M Schwarz, J Yuen, et al.
Circulation
|
April 27, 1999
Decreased activity of the L-arginine-nitric oxide metabolic pathway in patients with congestive heart failure
S D Katz, T Khan, G A Zeballos, et al.
Circulation
|
January 1, 1992
Control of arteriolar resistance in heart failure. Partial attenuation of specific phosphodiesterase inhibitor-mediated vasodilation by digitalis glycosides
G Jondeau, M Klapholz, S D Katz, et al.
Circulation
|
April 1, 1994
Enhancement of endothelium-dependent vasodilation by low-dose nitroglycerin in patients with congestive heart failure
M Schwarz, S D Katz, L Demopoulos, et al.
Circulation
|
November 1, 1992
Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure
G Jondeau, S D Katz, L Zohman, et al.
Circulation
|
July 1, 1994
Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation
S D Katz, R Rao, J W Berman, et al.
Circulation
|
December 15, 1996
Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial
L S Marcus, D Hart, M Packer, et al.
Circulation
|
April 1, 1997
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure
L Demopoulos, M Yeh, M Gentilucci, et al.
Circulation
|
March 2, 1999
Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure
G Hamroff, S D Katz, D Mancini, et al.
Page
of 2